Medtech Insight spoke with Sidley Austin attorneys about the future of medical device AI negligence litigation and what manufacturers can do to protect themselves.
An artificial intelligence/ machine learning (AI/ML) revolution is nigh, but not all developers are prepared for the potential product lawsuits that may be headed their way. Medtech Insight spoke to Elizabeth Curtin and Eva von Mühlenen, attorneys at Sidley Austin, about what the current legal landscape can tell us about the future of AI/ML negligence litigation and what companies can do to protect themselves.
Below is our podcast interview:
TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.
The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.
Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.
